emedicine.medscape.com Open in urlscan Pro
104.18.37.101  Public Scan

Submitted URL: http://www.emedicine.com//med//topic2821.htm
Effective URL: https://emedicine.medscape.com/article/775407-overview
Submission: On August 01 via api from US — Scanned from NL

Form analysis 3 forms found in the DOM

Name: SearchFormHeaderGET javascript:subsearchheadertrack('en');

<form name="SearchFormHeader" class="search-form-header" method="get" aria-label="Search" action="javascript:subsearchheadertrack('en');">
  <input type="hidden" value="news" name="searchSrc">
  <input id="search-input" class="search-input search-input-text" aria-label="Search" type="text" autocomplete="off" autocorrect="off" name="q" maxlength="500" placeholder="Search">
  <button type="submit" class="search-submit-button" aria-label="Search" title="search">
    <svg xmlns="https://www.w3.org/2000/svg" viewBox="0 0 21 21">
      <path fill="#005B80" fill-rule="evenodd"
        d="M12.018 12.468c-2.155 2.156-5.63 2.156-7.784 0-2.155-2.154-2.155-5.63 0-7.784 2.154-2.155 5.63-2.155 7.784 0 2.155 2.155 2.133 5.63 0 7.784M2.54 2.99c-3.078 3.08-3.078 8.07 0 11.15 2.727 2.727 6.927 3.035 10.006.946l5.168 5.167c.572.572 1.517.572 2.09 0 .57-.572.57-1.517 0-2.09l-5.17-5.166c2.09-3.08 1.782-7.28-.945-10.006-3.08-3.077-8.07-3.077-11.15 0">
      </path>
    </svg></button>
  <button type="button" class="search-open-button js-expand-button" data-section=".header-search" aria-label="Search">
    <svg xmlns="https://www.w3.org/2000/svg" viewBox="0 0 21 21">
      <path fill="#005B80" fill-rule="evenodd"
        d="M12.018 12.468c-2.155 2.156-5.63 2.156-7.784 0-2.155-2.154-2.155-5.63 0-7.784 2.154-2.155 5.63-2.155 7.784 0 2.155 2.155 2.133 5.63 0 7.784M2.54 2.99c-3.078 3.08-3.078 8.07 0 11.15 2.727 2.727 6.927 3.035 10.006.946l5.168 5.167c.572.572 1.517.572 2.09 0 .57-.572.57-1.517 0-2.09l-5.17-5.166c2.09-3.08 1.782-7.28-.945-10.006-3.08-3.077-8.07-3.077-11.15 0">
      </path>
    </svg></button>
  <div class="ilfulllist">
    <p class="il_combo_nor">No Results</p>
    <ul class="combolist"></ul>
  </div>
</form>

Name: SearchFormHeaderGET javascript:subsearchheadertrack('en');

<form name="SearchFormHeader" class="search-form-header" method="get" aria-label="Search" action="javascript:subsearchheadertrack('en');">
  <input type="hidden" value="news" name="searchSrc">
  <input id="layer-search-input" class="search-input search-input-text" aria-label="Search" type="text" autocomplete="off" autocorrect="off" name="q" maxlength="500" placeholder="Search">
  <button type="submit" class="search-submit-button" aria-label="Search" title="search">
    <svg xmlns="https://www.w3.org/2000/svg" viewBox="0 0 21 21">
      <path fill="#005B80" fill-rule="evenodd"
        d="M12.018 12.468c-2.155 2.156-5.63 2.156-7.784 0-2.155-2.154-2.155-5.63 0-7.784 2.154-2.155 5.63-2.155 7.784 0 2.155 2.155 2.133 5.63 0 7.784M2.54 2.99c-3.078 3.08-3.078 8.07 0 11.15 2.727 2.727 6.927 3.035 10.006.946l5.168 5.167c.572.572 1.517.572 2.09 0 .57-.572.57-1.517 0-2.09l-5.17-5.166c2.09-3.08 1.782-7.28-.945-10.006-3.08-3.077-8.07-3.077-11.15 0">
      </path>
    </svg></button>
  <div class="ilfulllist">
    <p class="il_combo_nor">No Results</p>
    <ul class="combolist"></ul>
  </div>
</form>

<form id="formGenerator">
  <div class="mdscp-form-generator">
    <div class="mdscp-form-generator-each-row  mdscp-regEmail">
      <div class="mdscp-textfield" component="TextField" validations="[object Object]" show="true" external="false" externalurl="" is-display-err="false" file-data="[object Object]"><label class="mdscp-label-field--regular"
          for="regEmail">Email</label>
        <div class="input-group"><input type="text" name="regEmail" placeholder="Enter your email address" class="form-control mdscp-text-field--regular" tabindex="" autocapitalize="none" maxlength="50"><!----></div>
      </div><label class="mdscp-error-slot mdscp-error-reg-default" style="display: none;"><img class="mdscp-error-slot-icon"
          src="data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAA8AAAAPCAYAAAA71pVKAAAAAXNSR0IArs4c6QAAAW9JREFUKBWdU71OAkEQnp0TjitRMWql1CTGv/gUdMYoJS0dDYSEhJaKkjegMFbyFEY44wtgpyYCpTkFbp1ZmHM5SEzc5tuZb76Znd1ZAGvpRgN9z7t+dN37nuu+9pLJL0a22c+8FQ5KjOdU6nAShnca4ER8caRgP4F4eRQEL8wZsRFq/aC1zohgs1CAVDYLwWAA405H3KCU+kgodcEJkI9iKlpCjkzn87BfrxuMlLThAiaedPjUbF6tO+pkNDIawaUE1BrrcBaGBZuQ/XQ4NFtB8QuyDqnpM3HYOBuPjSloc7xnHVITW3GC7cmisuBKDOmQrm/eXIydLnoWjNFUWo0UDwBVz6+QfzmU6qKD+PuIlsBJp2G7WISNTPT0FgvAOjyuVG55cpYYMnZKJThot2G3XI5TfFn+QgewbsK8XA72qlV4b7Xgs9+PEtgTRknm6z+zHf0SntXTWu3ccZwbuskuVXijzN+MbLOfefkUXPIHXLGoJEMBnxkAAAAASUVORK5CYII="></label><!---->
    </div>
    <div class="mdscp-form-generator-each-row  mdscp-isSocialEnable" style="display: none;"><input type="hidden" name="isSocialEnable" component="HiddenField" class="" file-data="[object Object]" value="true"><label
        class="mdscp-error-slot mdscp-error-reg-default" style="display: none;"><img class="mdscp-error-slot-icon"
          src="data:image/png;base64,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"></label><!---->
    </div>
    <div class="mdscp-form-generator-each-row  mdscp-linkedSites" style="display: none;"><input type="hidden" name="linkedSites" component="HiddenField" class="" file-data="[object Object]"><label class="mdscp-error-slot mdscp-error-reg-default"
        style="display: none;"><img class="mdscp-error-slot-icon"
          src="data:image/png;base64,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"></label><!---->
    </div>
  </div>
  <div class="mdscp-button reg-default"><button class="mdscp-button--submit mdscp-button--medium" data-event-tracking=""><!----><!----><span data-event-tracking="">Continue</span></button></div>
</form>

Text Content

This site is intended for healthcare professionals
News & Perspective
Drugs & Diseases
CME & Education
Video
Decision Point
Edition: English


Medscape

English
Deutsch
Español
Français
Português
UKNew

Univadis

Français New
Italiano New
Log In
Sign Up It's Free!
English Edition

Medscape

 * English
 * Deutsch
 * Español
 * Français
 * Português
 * UKNew

Univadis

 * Français New
 * Italiano New

X
Univadis from Medscape



Register Log In

No Results

No Results


News & Perspective Drugs & Diseases CME & Education Video Decision Point


close
Please confirm that you would like to log out of Medscape. If you log out, you
will be required to enter your username and password the next time you visit.
Log out Cancel

https://profreg.medscape.com/px/getpracticeprofile.do?method=getProfessionalProfile&urlCache=aHR0cHM6Ly9lbWVkaWNpbmUubWVkc2NhcGUuY29tL2FydGljbGUvNzc1NDA3LW92ZXJ2aWV3

processing....




Drugs & Diseases > Emergency Medicine


HEMORRHOIDS

Updated: May 31, 2022
 * Author: Kyle R Perry, MD; Chief Editor: John Geibel, MD, MSc, DSc, AGAF 
   more...

 * 82
 * Share
 * Print
 * Feedback

Close
 * Facebook
 * Twitter
 * LinkedIn
 * WhatsApp
 * Email


Sections
Hemorrhoids
   
 * Sections Hemorrhoids
 * Overview
     
     
   * Background
   * Anatomy
   * Etiology and Pathophysiology
   * Epidemiology
   * Prognosis
   * Show All
 * Presentation
     
     
   * History
   * Physical Examination
   * Grading of Internal Hemorrhoids
   * Show All
 * DDx
 * Workup
     
     
   * Approach Considerations
   * Hematologic Tests
   * Anoscopy and Flexible Sigmoidoscopy
   * Other Diagnostic Imaging Studies
   * Histologic Features
   * Show All
 * Treatment
     
     
   * Approach Considerations
   * Emergency Department Care
   * Conservative Management
   * Nonsurgical Procedures
   * Surgical Intervention
   * Long-Term Monitoring
   * Show All
 * Guidelines
 * Medication
     
     
   * Medication Summary
   * Stool softeners
   * Topical anesthetics
   * Mild astringent
   * Analgesics
   * Show All
 * Questions & Answers
 * Media Gallery
 * References

Overview


BACKGROUND

Hemorrhoids are swollen blood vessels in the lower rectum. They are among the
most common causes of anal pathology, and subsequently are blamed for virtually
any anorectal complaint by patients and medical professionals alike. Confusion
often arises because the term "hemorrhoid" has been used to refer to both normal
anatomic structures and pathologic structures. In the context of this article,
"hemorrhoids" refers to the pathologic presentation of hemorrhoidal venous
cushions.

Hemorrhoidal venous cushions are normal structures of the anorectum and are
anatomically present unless a previous intervention has taken place. Because of
their rich vascular supply, highly sensitive location, and tendency to engorge
and prolapse, hemorrhoidal venous cushions are common causes of anal pathology.
[1] Symptoms can range from mildly bothersome, such as pruritus, to quite
concerning, such as rectal bleeding.



Although hemorrhoids are a common condition diagnosed in clinical practice, many
patients are too embarrassed to seek treatment. Consequently, the true
prevalence of pathologic hemorrhoids is not known. [2] In addition, although
hemorrhoids are responsible for a large portion of anorectal complaints, it is
important to rule out more serious conditions, such as other causes of
gastrointestinal (GI) bleeding, before reflexively attributing symptoms to
hemorrhoids. [3]

In a study of 198 physicians from different specialties, Grucela et al found the
rate of correct identification for seven common, benign anal pathologic
conditions (including anal abscess, fissure, and fistula; prolapsed internal
hemorrhoid; thrombosed external hemorrhoid; condyloma acuminata; and
full-thickness rectal prolapse) was greatest for condylomata and rectal prolapse
and was lowest for hemorrhoidal conditions. [4] There was no correlation between
diagnostic accuracy and years of physician experience. The investigators found
the overall diagnostic accuracy among the physicians to be 53.5%, with the
accuracy for surgeons being 70.4% and that for the rest of the doctors being
less than 50%. [4]




HISTORICAL NOTE

Hemorrhoidal symptoms have historically been treated with dietary modifications,
incantations, voodoo, quackery, and application of a hot poker. Molten lead has
also been described as a treatment. The adverse effects of these treatments have
a direct relationship to whether patients relay persistent or recurrent
complaints to the clinician or return for further treatment.



For patient education information, see the Digestive Disorders Center as well as
Hemorrhoids, Anal Abscess, Rectal Pain, and Rectal Bleeding.



See also the following:

   

 * Anal Surgery for Hemorrhoids

   

 * Thrombosed External Hemorrhoid Excision



Next: Anatomy




ANATOMY

Hemorrhoids are not varicosities; they are clusters of vascular tissue (eg,
arterioles, venules, arteriolar-venular connections), smooth muscle (eg, Treitz
muscle), and connective tissue lined by the normal epithelium of the anal canal.
Hemorrhoids are present in utero and persist through normal adult life. Evidence
indicates that hemorrhoidal bleeding is arterial and not venous. This evidence
is supported by the bright red color and arterial pH of the blood.



Hemorrhoids are classified by their anatomic origin within the anal canal and by
their position relative to the dentate line; thus, they are categorized into
internal and external hemorrhoids (see the following image).


Hemorrhoids. Anatomy of external hemorrhoid. Image courtesy of MedicineNet, Inc.
View Media Gallery


External hemorrhoids develop from ectoderm and are covered by squamous
epithelium, whereas internal hemorrhoids are derived from embryonic endoderm and
lined with the columnar epithelium of anal mucosa. Similarly, external
hemorrhoids are innervated by cutaneous nerves that supply the perianal area.
These nerves include the pudendal nerve and the sacral plexus. Internal
hemorrhoids are not supplied by somatic sensory nerves and therefore cannot
cause pain. At the level of the dentate line, internal hemorrhoids are anchored
to the underlying muscle by the mucosal suspensory ligament.



Hemorrhoidal venous cushions are a normal part of the human anorectum and arise
from subepithelial connective tissue within the anal canal. Internal hemorrhoids
have three main cushions, which are situated in the left lateral, right
posterior (most common), and right anterior areas of the anal canal. However,
this combination is found in only 19% of patients; hemorrhoids can be found at
any position within the rectum. Minor tufts can be found between the major
cushions.



Present in utero, these cushions surround and support distal anastomoses between
the superior rectal arteries and the superior, middle, and inferior rectal
veins. They also contain a subepithelial smooth muscle layer, contributing to
the bulk of the cushions. Normal hemorrhoidal tissue accounts for approximately
15-20% of resting anal pressure and provides important sensory information,
enabling the differentiation between solid, liquid, and gas.



External hemorrhoidal veins are found circumferentially under the anoderm; they
can cause trouble anywhere around the circumference of the anus.



Venous drainage of hemorrhoidal tissue mirrors embryologic origin. Internal
hemorrhoids drain through the superior rectal vein into the portal system.
External hemorrhoids drain through the inferior rectal vein into the inferior
vena cava. Rich anastomoses exist between these two and the middle rectal vein,
connecting the portal and systemic circulations.



Mixed hemorrhoids are confluent internal and external hemorrhoids.



Previous
Next: Anatomy




ETIOLOGY AND PATHOPHYSIOLOGY

The term hemorrhoid is usually related to the symptoms caused by hemorrhoids.
Hemorrhoids are present in healthy individuals. In fact, hemorrhoidal columns
exist in utero. When these vascular cushions produce symptoms, they are referred
to as hemorrhoids. Hemorrhoids generally cause symptoms when they become
enlarged, inflamed, thrombosed, or prolapsed.



Most symptoms arise from enlarged internal hemorrhoids. Abnormal swelling of the
anal cushions causes dilatation and engorgement of the arteriovenous plexuses.
This leads to stretching of the suspensory muscles and eventual prolapse of
rectal tissue through the anal canal. The engorged anal mucosa is easily
traumatized, leading to rectal bleeding that is typically bright red due to high
blood oxygen content within the arteriovenous anastomoses. Prolapse leads to
soiling and mucus discharge (triggering pruritus) and predisposes to
incarceration and strangulation.



Although many patients and clinicians believe that hemorrhoids are caused by
chronic constipation, prolonged sitting, and vigorous straining, little evidence
to support a causative link exists. Some of these potential etiologies are
briefly discussed below.




DECREASED VENOUS RETURN

Most authors agree that low-fiber diets cause small-caliber stools, which result
in straining during defecation. This increased pressure causes engorgement of
the hemorrhoids, possibly by interfering with venous return. Pregnancy and
abnormally high tension of the internal sphincter muscle can also cause
hemorrhoidal problems, presumably by means of the same mechanism, which is
thought to be decreased venous return. Prolonged sitting on a toilet (eg, while
reading) is believed to cause a relative venous return problem in the perianal
area (a tourniquet effect), resulting in enlarged hemorrhoids. Aging causes
weakening of the support structures, which facilitates prolapse. Weakening of
support structures can occur as early as the third decade of life.




STRAINING AND CONSTIPATION

Straining and constipation have long been thought of as culprits in the
formation of hemorrhoids. This may or may not be true. [5, 6, 7] Patients who
report hemorrhoids have a canal resting tone that is higher than normal. Of
interest, the resting tone is lower after hemorrhoidectomy than it is before the
procedure. This change in resting tone is the mechanism of action of Lord
dilatation, a surgical procedure for anorectal complaints that is most commonly
performed in the United Kingdom.




PREGNANCY

Pregnancy clearly predisposes women to symptoms from hemorrhoids, although the
etiology is unknown. Notably, most patients revert to their previously
asymptomatic state after delivery. The relationship between pregnancy and
hemorrhoids lends credence to hormonal changes or direct pressure as the
culprit.




PORTAL HYPERTENSION AND ANORECTAL VARICES

Portal hypertension has often been mentioned in conjunction with hemorrhoids.
[8, 9, 10] However, hemorrhoidal symptoms do not occur more frequently in
patients with portal hypertension than in those without it, and massive bleeding
from hemorrhoids in these patients is unusual. Bleeding is very often
complicated by coagulopathy. If bleeding is found, direct suture ligation of the
offending column is suggested.



Anorectal varices are common in patients with portal hypertension. [11] Varices
occur in the midrectum, at connections between the portal system and the middle
and inferior rectal veins. Varices occur more frequently in patients who are
noncirrhotic, and they rarely bleed. Treatment is usually directed at the
underlying portal hypertension. Emergent control of bleeding can be obtained
with suture ligation. Portosystemic shunts and transjugular intrahepatic
portosystemic shunts (TIPS) have been used to control hypertension and thus, the
bleeding. [12]




OTHER RISK FACTORS

Other risk factors historically associated with the development of hemorrhoids
include the following:

   

 * Lack of erect posture

   

 * Familial tendency

   

 * Higher socioeconomic status

   

 * Chronic diarrhea

   

 * Colon malignancy

   

 * Hepatic disease

   

 * Obesity

   

 * Elevated anal resting pressure

   

 * Spinal cord injury

   

 * Loss of rectal muscle tone

   

 * Rectal surgery

   

 * Episiotomy

   

 * Anal intercourse

   

 * Inflammatory bowel disease, including ulcerative colitis, and Crohn disease




PATHOPHYSIOLOGY OF SYMPTOMS OF INTERNAL HEMORRHOIDS

Internal hemorrhoids cannot cause cutaneous pain, because they are above the
dentate line and are not innervated by cutaneous nerves. However, they can
bleed, prolapse, and, as a result of the deposition of an irritant onto the
sensitive perianal skin, cause perianal itching and irritation. Internal
hemorrhoids can produce perianal pain by prolapsing and causing spasm of the
sphincter complex around the hemorrhoids. This spasm results in discomfort while
the prolapsed hemorrhoids are exposed. This muscle discomfort is relieved with
reduction.



Internal hemorrhoids can also cause acute pain when incarcerated and
strangulated. Again, the pain is related to the sphincter complex spasm.
Strangulation with necrosis may cause more deep discomfort. When these
catastrophic events occur, the sphincter spasm often causes concomitant external
thrombosis. External thrombosis causes acute cutaneous pain. This constellation
of symptoms is referred to as acute hemorrhoidal crisis and usually requires
emergent treatment.



Internal hemorrhoids most commonly cause painless bleeding with bowel movements.
The covering epithelium is damaged by the hard bowel movement, and the
underlying veins bleed. With spasm of the sphincter complex elevating pressure,
the internal hemorrhoidal veins can spurt.



Internal hemorrhoids can deposit mucus onto the perianal tissue with prolapse.
This mucus with microscopic stool contents can cause a localized dermatitis,
which is called pruritus ani. Generally, hemorrhoids are merely the vehicle by
which the offending elements reach the perianal tissue. Hemorrhoids are not the
primary offenders.




PATHOPHYSIOLOGY OF SYMPTOMS OF EXTERNAL HEMORRHOIDS

External hemorrhoids cause symptoms in two ways. First, acute thrombosis of the
underlying external hemorrhoidal vein can occur. Acute thrombosis is usually
related to a specific event, such as physical exertion, straining with
constipation, a bout of diarrhea, or a change in diet. These are acute, painful
events.



Pain results from rapid distention of innervated skin by the clot and
surrounding edema. The pain lasts 7-14 days and resolves with resolution of the
thrombosis. With this resolution, the stretched anoderm persists as excess skin
or skin tags. External thromboses occasionally erode the overlying skin and
cause bleeding. Recurrence occurs approximately 40-50% of the time, at the same
site (because the underlying damaged vein remains there). Simply removing the
blood clot and leaving the weakened vein in place, rather than excising the
offending vein with the clot, will predispose the patient to recurrence.



External hemorrhoids can also cause hygiene difficulties, with the excess,
redundant skin left after an acute thrombosis (skin tags) being accountable for
these problems. External hemorrhoidal veins found under the perianal skin
obviously cannot cause hygiene problems; however, excess skin in the perianal
area can mechanically interfere with cleansing.



Previous
Next: Anatomy




EPIDEMIOLOGY

Worldwide, the prevalence of symptomatic hemorrhoids is estimated at 4.4% in the
general population. In the United States, up to one third of the 10 million
people with hemorrhoids seek medical treatment, resulting in 1.5 million related
prescriptions per year.



The number of hemorrhoidectomies performed in US hospitals is declining. A peak
of 117 hemorrhoidectomies per 100,000 people was reached in 1974; this rate
declined to 37 hemorrhoidectomies per 100,000 people in 1987. Outpatient and
office treatment of hemorrhoids account for some of this decline.



Patients presenting with hemorrhoidal disease are more frequently white, from
higher socioeconomic status, and from rural areas. There is no known sex
predilection, although men are more likely to seek treatment. However, pregnancy
causes physiologic changes that predispose women to developing symptomatic
hemorrhoids. As the gravid uterus expands, it compresses the inferior vena cava,
causing decreased venous return and distal engorgement.



External hemorrhoids occur more commonly in young and middle-aged adults than in
older adults. The prevalence of hemorrhoids increases with age, with a peak in
persons aged 45-65 years.



Previous
Next: Anatomy




PROGNOSIS

Most hemorrhoids resolve spontaneously or with conservative medical therapy
alone. However, complications can include thrombosis, secondary infection,
ulceration, abscess, and incontinence. The recurrence rate with nonsurgical
techniques is 10-50% over a 5-year period, whereas that of surgical
hemorrhoidectomy is less than 5%.



Regarding complications from surgery, well-trained surgeons should experience
complications in fewer than 5% of cases. Complications include stenosis,
bleeding, infection, recurrence, nonhealing wounds, and fistula formation.
Urinary retention is directly related to the anesthetic technique used and to
the perioperative fluids administered. Limiting fluids and the routine use of
local anesthesia can reduce urinary retention to less than 5%.



Previous

Clinical Presentation
 
 

REFERENCES

 1.  Marx JA, Hockberger RS, Walls RM, et al, eds. Rosen's Emergency Medicine:
     Concepts and Clinical Practice. 6th ed. Philadelphia, Pa: Elsevier; 2006.
     1509-12.

 2.  Tintinalli JE, Kelen GD, Stapczynski JS, eds. Emergency Medicine: A
     Comprehensive Study Guide. 6th ed. New York, NY: McGraw Hill; 2004. 540-1.

 3.  Ibrahim AM, Hackford AW, Lee YM, Cave DR. Hemorrhoids can be a source of
     obscure gastrointestinal bleeding that requires transfusion: report of five
     patients. Dis Colon Rectum. 2008 Aug. 51(8):1292-4. [QxMD MEDLINE Link].

 4.  Grucela A, Salinas H, Khaitov S, Steinhagen RM, Gorfine SR, Chessin DB.
     Prospective analysis of clinician accuracy in the diagnosis of benign anal
     pathology: comparison across specialties and years of experience. Dis Colon
     Rectum. 2010 Jan. 53(1):47-52. [QxMD MEDLINE Link].

 5.  Gibbons CP, Bannister JJ, Read NW. Role of constipation and anal hypertonia
     in the pathogenesis of haemorrhoids. Br J Surg. 1988 Jul. 75(7):656-60.
     [QxMD MEDLINE Link].

 6.  Johanson JF, Sonnenberg A. The prevalence of hemorrhoids and chronic
     constipation. An epidemiologic study. Gastroenterology. 1990 Feb.
     98(2):380-6. [QxMD MEDLINE Link].

 7.  Johanson JF, Sonnenberg A. Constipation is not a risk factor for
     hemorrhoids: a case-control study of potential etiological agents. Am J
     Gastroenterol. 1994 Nov. 89(11):1981-6. [QxMD MEDLINE Link].

 8.  Bernstein WC. What are hemorrhoids and what is their relationship to the
     portal venous system?. Dis Colon Rectum. 1983 Dec. 26(12):829-34. [QxMD
     MEDLINE Link].

 9.  Hosking SW, Smart HL, Johnson AG, Triger DR. Anorectal varices,
     haemorrhoids, and portal hypertension. Lancet. 1989 Feb 18. 1(8634):349-52.
     [QxMD MEDLINE Link].

 10. Johansen K, Bardin J, Orloff MJ. Massive bleeding from hemorrhoidal varices
     in portal hypertension. JAMA. 1980 Nov 7. 244(18):2084-5. [QxMD MEDLINE
     Link].

 11. Chawla Y, Dilawari JB. Anorectal varices--their frequency in cirrhotic and
     non-cirrhotic portal hypertension. Gut. 1991 Mar. 32(3):309-11. [QxMD
     MEDLINE Link]. [Full Text].

 12. Katz JA, Rubin RA, Cope C, Holland G, Brass CA. Recurrent bleeding from
     anorectal varices: successful treatment with a transjugular intrahepatic
     portosystemic shunt. Am J Gastroenterol. 1993 Jul. 88(7):1104-7. [QxMD
     MEDLINE Link].

 13. D'Ugo S, Stasi E, Gaspari AL, Sileri P. Hemorrhoids and anal fissures in
     inflammatory bowel disease. Minerva Gastroenterol Dietol. 2015 Dec.
     61(4):223-33. [QxMD MEDLINE Link].

 14. [Guideline] Davis BR, Lee-Kong SA, Migaly J, Feingold DL, Steele SR. The
     American Society of Colon and Rectal Surgeons Clinical Practice Guidelines
     for the Management of Hemorrhoids. Dis Colon Rectum. 2018 Mar.
     61(3):284-92. [QxMD MEDLINE Link]. [Full Text].

 15. [Guideline] Rubbini M, Ascanelli S. Classification and guidelines of
     hemorrhoidal disease: present and future. World J Gastrointest Surg. 2019
     Mar 27. 11(3):117-21. [QxMD MEDLINE Link]. [Full Text].

 16. Rubbini M, Ascanelli S, Fabbian F. Hemorrhoidal disease: is it time for a
     new classification?. Int J Colorectal Dis. 2018 Jun. 33(6):831-3. [QxMD
     MEDLINE Link].

 17. [Guideline] Wald A, Bharucha AE, Limketkai B, et al. ACG Clinical
     guidelines: management of benign anorectal disorders. Am J Gastroenterol.
     2021 Oct 1. 116(10):1987-2008. [QxMD MEDLINE Link]. [Full Text].

 18. [Guideline] Mott T, Latimer K, Edwards C. Hemorrhoids: diagnosis and
     treatment options. Am Fam Physician. 2018 Feb 1. 97(3):172-9. [QxMD MEDLINE
     Link]. [Full Text].

 19. [Guideline] Tarasconi A, Perrone G, Davies J, et al. Anorectal emergencies:
     WSES-AAST guidelines. World J Emerg Surg. 2021 Sep 16. 16(1):48. [QxMD
     MEDLINE Link]. [Full Text].

 20. [Guideline] Wolf AMD, Fontham ETH, Church TR, et al. Colorectal cancer
     screening for average-risk adults: 2018 guideline update from the American
     Cancer Society. CA Cancer J Clin. 2018 Jul. 68(4):250-81. [QxMD MEDLINE
     Link]. [Full Text].

 21. American Gastroenterological Association medical position statement:
     Diagnosis and treatment of hemorrhoids. Gastroenterology. 2004 May.
     126(5):1461-2. [QxMD MEDLINE Link].

 22. [Guideline] Rivadeneira DE, Steele SR, Ternent C, et al. Practice
     parameters for the management of hemorrhoids (revised 2010). Dis Colon
     Rectum. 2011 Sep. 54(9):1059-64. [QxMD MEDLINE Link].

 23. [Guideline] Wald A, Bharucha AE, Cosman BC, et al. ACG clinical guideline:
     management of benign anorectal disorders. Am J Gastroenterol. 2014 Aug.
     109(8):1141-57; (Quiz) 1058. [QxMD MEDLINE Link]. [Full Text].

 24. Chen HL, Woo XB, Cui J, et al. Ligasure versus stapled hemorrhoidectomy in
     the treatment of hemorrhoids: a meta-analysis of randomized control trials.
     Surg Laparosc Endosc Percutan Tech. 2014 Aug. 24(4):285-9. [QxMD MEDLINE
     Link].

 25. El Nakeeb AM, Fikry AA, Omar WH, et al. Rubber band ligation for 750 cases
     of symptomatic hemorrhoids out of 2200 cases. World J Gastroenterol. 2008
     Nov 14. 14(42):6525-30. [QxMD MEDLINE Link]. [Full Text].

 26. Raahave D, Jepsen LV, Pedersen IK. Primary and repeated stapled
     hemorrhoidopexy for prolapsing hemorrhoids: follow-up to five years. Dis
     Colon Rectum. 2008 Mar. 51(3):334-41. [QxMD MEDLINE Link].

 27. Jayaraman S, Colquhoun PH, Malthaner RA. Stapled hemorrhoidopexy is
     associated with a higher long-term recurrence rate of internal hemorrhoids
     compared with conventional excisional hemorrhoid surgery. Dis Colon Rectum.
     2007 Sep. 50(9):1297-305. [QxMD MEDLINE Link].

 28. Ceci F, Picchio M, Palimento D, Cali B, Corelli S, Spaziani E. Long-term
     outcome of stapled hemorrhoidopexy for Grade III and Grade IV hemorrhoids.
     Dis Colon Rectum. 2008 Jul. 51(7):1107-12. [QxMD MEDLINE Link].

 29. Moesgaard F, Nielsen ML, Hansen JB, Knudsen JT. High-fiber diet reduces
     bleeding and pain in patients with hemorrhoids: a double-blind trial of
     Vi-Siblin. Dis Colon Rectum. 1982 Jul-Aug. 25(5):454-6. [QxMD MEDLINE
     Link].

 30. Perera N, Liolitsa D, Iype S, et al. Phlebotonics for haemorrhoids.
     Cochrane Database Syst Rev. 2012 Aug 15. 8:CD004322. [QxMD MEDLINE Link].

 31. Hollingshead JR, Phillips RK. Haemorrhoids: modern diagnosis and treatment.
     Postgrad Med J. 2016 Jan. 92(1083):4-8. [QxMD MEDLINE Link].

 32. Gorfine SR. Treatment of benign anal disease with topical nitroglycerin.
     Dis Colon Rectum. 1995 May. 38(5):453-6; discussion 456-7. [QxMD MEDLINE
     Link].

 33. Perrotti P, Antropoli C, Molino D, De Stefano G, Antropoli M. Conservative
     treatment of acute thrombosed external hemorrhoids with topical nifedipine.
     Dis Colon Rectum. 2001 Mar. 44(3):405-9. [QxMD MEDLINE Link].

 34. Yuksel BC, Armagan H, Berkem H, Yildiz Y, Ozel H, Hengirmen S. Conservative
     management of hemorrhoids: a comparison of venotonic flavonoid micronized
     purified flavonoid fraction (MPFF) and sclerotherapy. Surg Today. 2008.
     38(2):123-9. [QxMD MEDLINE Link].

 35. Faucheron JL, Gangner Y. Doppler-guided hemorrhoidal artery ligation for
     the treatment of symptomatic hemorrhoids: early and three-year follow-up
     results in 100 consecutive patients. Dis Colon Rectum. 2008 Jun.
     51(6):945-9. [QxMD MEDLINE Link].

 36. Johanson JF, Rimm A. Optimal nonsurgical treatment of hemorrhoids: a
     comparative analysis of infrared coagulation, rubber band ligation, and
     injection sclerotherapy. Am J Gastroenterol. 1992 Nov. 87(11):1600-6. [QxMD
     MEDLINE Link].

 37. Saleeby RG Jr, Rosen L, Stasik JJ, Riether RD, Sheets J, Khubchandani IT.
     Hemorrhoidectomy during pregnancy: risk or relief?. Dis Colon Rectum. 1991
     Mar. 34(3):260-1. [QxMD MEDLINE Link].

 38. Blaisdell PC. Prevention of massive hemorrhage secondary to
     hemorrhoidectomy. Surg Gynecol Obstet. 1958 Apr. 106(4):485-8. [QxMD
     MEDLINE Link].

 39. Barron J. Office ligation treatment of hemorrhoids. Dis Colon Rectum. 1963
     Mar-Apr. 6:109-13. [QxMD MEDLINE Link].

 40. Jutabha R, Jensen DM, Chavalitdhamrong D. Randomized prospective study of
     endoscopic rubber band ligation compared with bipolar coagulation for
     chronically bleeding internal hemorrhoids. Am J Gastroenterol. 2009 Aug.
     104(8):2057-64. [QxMD MEDLINE Link].

 41. Loh WL, Tan S, Ngooi MS, Ong ZK, Ngoi SS. Endoscopic monopolar coagulation
     of internal haemorrhoids: a surgeon's experience of the first 100 cases.
     Colorectal Dis. 2017 Jan. 19(1):O86-9. [QxMD MEDLINE Link].

 42. Senapati A, Nicholls RJ. A randomised trial to compare the results of
     injection sclerotherapy with a bulk laxative alone in the treatment of
     bleeding haemorrhoids. Int J Colorectal Dis. 1988 Jun. 3(2):124-6. [QxMD
     MEDLINE Link].

 43. Thornton SC. Sclerotherapy of hemorrhoids. Selected Topics in Colon and
     Rectal Surgery. Vol 5. Norwalk, Conn: Konsyl Pharmaceuticals; 1992:72-5.:

 44. Gupta PJ, Kalaskar S. Radiowave ablation and mucopexy for prolapsing
     hemorrhoids--a pilot study. Int J Surg. 2009 Jun. 7(3):223-7. [QxMD MEDLINE
     Link].

 45. Simillis C, Thoukididou SN, Slesser AA, Rasheed S, Tan E, Tekkis PP.
     Systematic review and network meta-analysis comparing clinical outcomes and
     effectiveness of surgical treatments for haemorrhoids. Br J Surg. 2015 Dec.
     102(13):1603-18. [QxMD MEDLINE Link].

 46. Leff EI. Hemorrhoidectomy--laser vs. nonlaser: outpatient surgical
     experience. Dis Colon Rectum. 1992 Aug. 35(8):743-6. [QxMD MEDLINE Link].

 47. Corman M. Hemorrhoid. Corman M. Colon and Rectal Surgery. Philadelphia, Pa:
     Lippincott-Raven; 1998. 154-6.

 48. Mazier WP. Hemorrhoids: surgery of the colon. Maxier WP, Levm DH,
     Luchtefeld. MA, Senagore AJ, eds. Rectum and Anus. Philadelphia, Pa: WB
     Saunders; 1995. 229-54.

 49. Esser S, Khubchandani I, Rakhmanine M. Stapled hemorrhoidectomy with local
     anesthesia can be performed safely and cost-efficiently. Dis Colon Rectum.
     2004 Jul. 47(7):1164-9. [QxMD MEDLINE Link].

 50. Ho YH, Cheong WK, Tsang C, et al. Stapled hemorrhoidectomy--cost and
     effectiveness. Randomized, controlled trial including incontinence scoring,
     anorectal manometry, and endoanal ultrasound assessments at up to three
     months. Dis Colon Rectum. 2000 Dec. 43(12):1666-75. [QxMD MEDLINE Link].

 51. Senagore AJ, Singer M, Abcarian H, et al. A prospective, randomized,
     controlled multicenter trial comparing stapled hemorrhoidopexy and Ferguson
     hemorrhoidectomy: perioperative and one-year results. Dis Colon Rectum.
     2004 Nov. 47(11):1824-36. [QxMD MEDLINE Link].

 52. Behboo R, Zanella S, Ruffolo C, Vafai M, Marino F, Scarpa M. Stapled
     haemorrhoidopexy: extent of tissue excision and clinical implications in
     the early postoperative period. Colorectal Dis. 2011 Jun. 13(6):697-702.
     [QxMD MEDLINE Link].

 53. Pattana-arun J, Wesarachawit W, Tantiphlachiva K, Atithansakul P,
     Sahakitrungruang C, Rojanasakul A. A comparison of early postoperative
     results between urgent closed hemorrhoidectomy for prolapsed thrombosed
     hemorrhoids and elective closed hemorrhoidectomy. J Med Assoc Thai. 2009
     Dec. 92(12):1610-5. [QxMD MEDLINE Link].

 54. Bove A, Bongarzoni G, Palone G, Chiarini S, Calisesi EM, Corbellini L.
     Effective treatment of haemorrhoids: early complication and late results
     after 150 consecutive stapled haemorrhoidectomies. Ann Ital Chir. 2009
     Jul-Aug. 80(4):299-303. [QxMD MEDLINE Link].

 55. Ratto C, Parello A, Veronese E, et al. Doppler-guided transanal
     haemorrhoidal dearterialization for haemorrhoids: results from a
     multicentre trial. Colorectal Dis. 2015 Jan. 17(1):O10-9. [QxMD MEDLINE
     Link].

 56. Bjelanovic Z, Draskovic M, Veljovic M, Lekovic I, Karanikolas M,
     Stamenkovic D. Transanal hemorrhoid dearterialization is a safe and
     effective outpatient procedure for the treatment of hemorrhoidal disease.
     Cir Esp. 2016 Dec. 94(10):588-94. [QxMD MEDLINE Link].

 57. Scheyer M, Antonietti E, Rollinger G, Lancee S, Pokorny H. Hemorrhoidal
     artery ligation (HAL) and rectoanal repair (RAR): retrospective analysis of
     408 patients in a single center. Tech Coloproctol. 2015 Jan. 19(1):5-9.
     [QxMD MEDLINE Link].

 58. Perrotti P, Dominici P, Grossi E, Cerutti R, Antropoli C. Topical
     nifedipine with lidocaine ointment versus active control for pain after
     hemorrhoidectomy: results of a multicentre, prospective, randomized,
     double-blind study. Can J Surg. 2010 Feb. 53(1):17-24. [QxMD MEDLINE Link].
     [Full Text].

 59. [Guideline] Russell MM, Ko CY. Management of hemorrhoids: mainstay of
     treatment remains diet modification and office-based procedures. National
     Guideline Clearinghouse. Available at
     https://guideline.gov/expert/expert-commentary.aspx?id=37828. Accessed:
     October 11, 2014.

 60. Elbetti C, Giani I, Novelli E, Fucini C, Martellucci J. The single pile
     classification: a new tool for the classification of haemorrhoidal disease
     and the comparison of treatment results. Updates Surg. 2015 Dec.
     67(4):421-6. [QxMD MEDLINE Link].

 61. Vinson-Bonnet B, Higuero T, Faucheron JL, Senejoux A, Pigot F, Siproudhis
     L. Ambulatory haemorrhoidal surgery: systematic literature review and
     qualitative analysis. Int J Colorectal Dis. 2015 Apr. 30(4):437-45. [QxMD
     MEDLINE Link].

 62. Milito G, Lisi G, Aronadio E, et al. LigasureTM hemorrhoidectomy: how we
     do. Minerva Gastroenterol Dietol. 2017 Mar. 63(1):44-9. [QxMD MEDLINE
     Link].

 63. Crawshaw BP, Russ AJ, Ermlich BO, Delaney CP, Champagne BJ. Prospective
     case series of a novel minimally invasive bipolar coagulation system in the
     treatment of grade I and II internal hemorrhoids. Surg Innov. 2016 Dec.
     23(6):581-5. [QxMD MEDLINE Link].

 64. [Guideline] Yamana T. Japanese practice guidelines for anal disorders. I.
     Hemorrhoids. J Anus Rectum Colon. 2017. 1(3):89-99. [QxMD MEDLINE Link].
     [Full Text].

Media Gallery
   
   
 * Hemorrhoids. Anatomy of external hemorrhoid. Image courtesy of MedicineNet,
   Inc.
   
 * Hemorrhoids. Thrombosed hemorrhoid. This hemorrhoid was treated by incision
   and removal of a clot.


of 2

TABLES

Back to List

CONTRIBUTOR INFORMATION AND DISCLOSURES

Author

Kyle R Perry, MD Emergency Physician, The Queen's Medical Center; Volunteer
Faculty, University of Hawaii, John A Burns School of Medicine

Disclosure: Nothing to disclose.

Specialty Editor Board

Francisco Talavera, PharmD, PhD Adjunct Assistant Professor, University of
Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug
Reference

Disclosure: Received salary from Medscape for employment. for: Medscape.

William G Gossman, MD, FAAEM Associate Clinical Professor of Emergency Medicine,
Creighton University School of Medicine; Chairman, Department of Emergency
Medicine, Creighton University Medical Center

William G Gossman, MD, FAAEM is a member of the following medical societies:
American Academy of Emergency Medicine

Disclosure: Nothing to disclose.

Chief Editor

John Geibel, MD, MSc, DSc, AGAF Vice Chair and Professor, Department of Surgery,
Section of Gastrointestinal Medicine, Professor, Department of Cellular and
Molecular Physiology, Yale University School of Medicine; Director of Surgical
Research, Department of Surgery, Yale-New Haven Hospital; American
Gastroenterological Association Fellow; Fellow of the Royal Society of Medicine

John Geibel, MD, MSc, DSc, AGAF is a member of the following medical societies:
American Gastroenterological Association, American Physiological Society,
American Society of Nephrology, Association for Academic Surgery, International
Society of Nephrology, New York Academy of Sciences, Society for Surgery of the
Alimentary Tract

Disclosure: Nothing to disclose.

Additional Contributors

Brian J Daley, MD, MBA, FACS, FCCP, CNSC Professor and Program Director,
Department of Surgery, Chief, Division of Trauma and Critical Care, University
of Tennessee Health Science Center College of Medicine

Brian J Daley, MD, MBA, FACS, FCCP, CNSC is a member of the following medical
societies: American Association for the Surgery of Trauma, Eastern Association
for the Surgery of Trauma, Southern Surgical Association, American College of
Chest Physicians, American College of Surgeons, American Medical Association,
Association for Academic Surgery, Association for Surgical Education, Shock
Society, Society of Critical Care Medicine, Southeastern Surgical Congress,
Tennessee Medical Association

Disclosure: Nothing to disclose.

Scott C Thornton, MD Associate Clinical Professor of Surgery, Yale University
School of Medicine; Director, Colorectal Teaching, Bridgeport Hospital; Private
Practice, Park Avenue Surgical Associates

Scott C Thornton, MD is a member of the following medical societies: American
Society of Colon and Rectal Surgeons

Disclosure: Nothing to disclose.

Adam J Rosh, MD Assistant Professor, Program Director, Emergency Medicine
Residency, Department of Emergency Medicine, Detroit Receiving Hospital, Wayne
State University School of Medicine

Adam J Rosh, MD is a member of the following medical societies: American Academy
of Emergency Medicine, American College of Emergency Physicians, Society for
Academic Emergency Medicine

Disclosure: Nothing to disclose.

Acknowledgements

The authors and editors of Medscape Reference gratefully acknowledge the
contributions of previous authors David R Gurley, MD, Richard Sinert, DO, and
Pilar Guerrero, MD,to the development and writing of a source article.

Close

WHAT WOULD YOU LIKE TO PRINT?

What would you like to print?
 * Print this section
 * Print the entire contents of
 * Print the entire contents of article

TOP PICKS FOR YOU




encoded search term (Hemorrhoids) and Hemorrhoids
What to Read Next on Medscape
Related Conditions and Diseases
 * Thrombosed External Hemorrhoid Excision
 * Anal Surgery for Hemorrhoids
 * Internal Hemorrhoid Band Ligation
 * Hemorrhoidectomy, Hemorrhoidopexy, and Hemorrhoid Artery Ligation
 * Rubber-Band Ligation of Hemorrhoids
 * Fast Five Quiz: Hemorrhoids Practice Essentials

News & Perspective
 * NordICC Controversies: Practice Differences in Europe and the US
 * Young-Onset Colorectal Cancer: How Do We Move Forward?
 * Mixed CRC Screening Messaging. Confusing? Some Docs Think So

Tools
 * Drug Interaction Checker
 * Pill Identifier
 * Calculators
 * Formulary

Slideshow
Disorders of Defecation: Too Little, Too Much

Recommended
 * 20021829718-overviewProcedures
   Procedures Internal Hemorrhoid Band Ligation
 * 200281039-overviewProcedures
   Procedures Thrombosed External Hemorrhoid Excision

   
 * Sections Hemorrhoids
 * Overview
     
     
   * Background
   * Anatomy
   * Etiology and Pathophysiology
   * Epidemiology
   * Prognosis
   * Show All
 * Presentation
     
     
   * History
   * Physical Examination
   * Grading of Internal Hemorrhoids
   * Show All
 * DDx
 * Workup
     
     
   * Approach Considerations
   * Hematologic Tests
   * Anoscopy and Flexible Sigmoidoscopy
   * Other Diagnostic Imaging Studies
   * Histologic Features
   * Show All
 * Treatment
     
     
   * Approach Considerations
   * Emergency Department Care
   * Conservative Management
   * Nonsurgical Procedures
   * Surgical Intervention
   * Long-Term Monitoring
   * Show All
 * Guidelines
 * Medication
     
     
   * Medication Summary
   * Stool softeners
   * Topical anesthetics
   * Mild astringent
   * Analgesics
   * Show All
 * Questions & Answers
 * Media Gallery
 * References



Medscape

Log in or register for free to unlock more Medscape content

Unlimited access to our entire network of sites and services

Log in or Register
Log in or register for free to unlock more Medscape content
Unlimited access to industry-leading news, research, resources, and more
Email



Continue

--------------------------------------------------------------------------------

or

--------------------------------------------------------------------------------

Log in with Google
Log in with Apple

Find Us On
About
About Medscape Privacy Policy Editorial Policy Cookies Manage Preferences Terms
of Use Advertising Policy Help Center
Membership
Become a Member About You Professional Information Newsletters & Alerts
Advertise Market Research
App
Medscape
Editions
English Deutsch Español Français Português UK
All material on this website is protected by copyright, Copyright © 1994-2024 by
WebMD LLC. This website also contains material copyrighted by 3rd parties.
Close




WE CARE ABOUT YOUR PRIVACY

We and our 63 partners store and/or access information on a device, such as
unique IDs in cookies to process personal data. You may accept or manage your
choices by clicking below, including your right to object where legitimate
interest is used, or at any time in the privacy policy page. These choices will
be signaled to our partners and will not affect browsing data.


WE AND OUR PARTNERS PROCESS DATA TO PROVIDE:

Use precise geolocation data. Actively scan device characteristics for
identification. Store and/or access information on a device. Personalised
advertising and content, advertising and content measurement, audience research
and services development. List of Partners (vendors)

I Accept Show Purposes



ABOUT YOUR PRIVACY

We process your data to deliver content or advertisements and measure the
delivery of such content or advertisements to extract insights about our
website. We share this information with our partners on the basis of consent and
legitimate interest. You may exercise your right to consent or object to a
legitimate interest, based on a specific purpose below or at a partner level in
the link under each purpose. These choices will be signaled to our vendors
participating in the Transparency and Consent Framework.
Opt Out Form
Allow All


MANAGE CONSENT PREFERENCES

STRICTLY NECESSARY COOKIES

Always Active

These cookies are necessary for the website to function and cannot be switched
off in our systems. They are usually only set in response to actions made by you
which amount to a request for services, such as setting your privacy
preferences, logging in or filling in forms. You can set your browser to block
or alert you about these cookies, but some parts of the site will not then work.
These cookies do not store any personally identifiable information.

TARGETING COOKIES

Targeting Cookies

These cookies may be set through our site by our advertising partners. They may
be used by those companies to build a profile of your interests and show you
relevant adverts on other sites. They do not store directly personal
information, but are based on uniquely identifying your browser and internet
device. If you do not allow these cookies, you will experience less targeted
advertising.

PERFORMANCE COOKIES

Performance Cookies

These cookies allow us to count visits and traffic sources so we can measure and
improve the performance of our site. They help us to know which pages are the
most and least popular and see how visitors move around the site. All
information these cookies collect is aggregated and therefore anonymous. If you
do not allow these cookies we will not know when you have visited our site, and
will not be able to monitor its performance.

FUNCTIONAL COOKIES

Functional Cookies

These cookies enable the website to provide enhanced functionality and
personalisation. They may be set by us or by third party providers whose
services we have added to our pages. If you do not allow these cookies then some
or all of these services may not function properly.

STORE AND/OR ACCESS INFORMATION ON A DEVICE 55 PARTNERS CAN USE THIS PURPOSE

Store and/or access information on a device

Cookies, device or similar online identifiers (e.g. login-based identifiers,
randomly assigned identifiers, network based identifiers) together with other
information (e.g. browser type and information, language, screen size, supported
technologies etc.) can be stored or read on your device to recognise it each
time it connects to an app or to a website, for one or several of the purposes
presented here.

List of IAB Vendors‎ | View Illustrations 

PERSONALISED ADVERTISING AND CONTENT, ADVERTISING AND CONTENT MEASUREMENT,
AUDIENCE RESEARCH AND SERVICES DEVELOPMENT 62 PARTNERS CAN USE THIS PURPOSE

Personalised advertising and content, advertising and content measurement,
audience research and services development

 * USE LIMITED DATA TO SELECT ADVERTISING 52 PARTNERS CAN USE THIS PURPOSE
   
   Switch Label
   
   Advertising presented to you on this service can be based on limited data,
   such as the website or app you are using, your non-precise location, your
   device type or which content you are (or have been) interacting with (for
   example, to limit the number of times an ad is presented to you).
   
   View Illustrations 
   Object to Legitimate Interests Remove Objection

 * CREATE PROFILES FOR PERSONALISED ADVERTISING 42 PARTNERS CAN USE THIS PURPOSE
   
   Switch Label
   
   Information about your activity on this service (such as forms you submit,
   content you look at) can be stored and combined with other information about
   you (for example, information from your previous activity on this service and
   other websites or apps) or similar users. This is then used to build or
   improve a profile about you (that might include possible interests and
   personal aspects). Your profile can be used (also later) to present
   advertising that appears more relevant based on your possible interests by
   this and other entities.
   
   View Illustrations 

 * USE PROFILES TO SELECT PERSONALISED ADVERTISING 42 PARTNERS CAN USE THIS
   PURPOSE
   
   Switch Label
   
   Advertising presented to you on this service can be based on your advertising
   profiles, which can reflect your activity on this service or other websites
   or apps (like the forms you submit, content you look at), possible interests
   and personal aspects.
   
   View Illustrations 

 * CREATE PROFILES TO PERSONALISE CONTENT 15 PARTNERS CAN USE THIS PURPOSE
   
   Switch Label
   
   Information about your activity on this service (for instance, forms you
   submit, non-advertising content you look at) can be stored and combined with
   other information about you (such as your previous activity on this service
   or other websites or apps) or similar users. This is then used to build or
   improve a profile about you (which might for example include possible
   interests and personal aspects). Your profile can be used (also later) to
   present content that appears more relevant based on your possible interests,
   such as by adapting the order in which content is shown to you, so that it is
   even easier for you to find content that matches your interests.
   
   View Illustrations 

 * USE PROFILES TO SELECT PERSONALISED CONTENT 13 PARTNERS CAN USE THIS PURPOSE
   
   Switch Label
   
   Content presented to you on this service can be based on your content
   personalisation profiles, which can reflect your activity on this or other
   services (for instance, the forms you submit, content you look at), possible
   interests and personal aspects. This can for example be used to adapt the
   order in which content is shown to you, so that it is even easier for you to
   find (non-advertising) content that matches your interests.
   
   View Illustrations 

 * MEASURE ADVERTISING PERFORMANCE 58 PARTNERS CAN USE THIS PURPOSE
   
   Switch Label
   
   Information regarding which advertising is presented to you and how you
   interact with it can be used to determine how well an advert has worked for
   you or other users and whether the goals of the advertising were reached. For
   instance, whether you saw an ad, whether you clicked on it, whether it led
   you to buy a product or visit a website, etc. This is very helpful to
   understand the relevance of advertising campaigns.
   
   View Illustrations 
   Object to Legitimate Interests Remove Objection

 * MEASURE CONTENT PERFORMANCE 21 PARTNERS CAN USE THIS PURPOSE
   
   Switch Label
   
   Information regarding which content is presented to you and how you interact
   with it can be used to determine whether the (non-advertising) content e.g.
   reached its intended audience and matched your interests. For instance,
   whether you read an article, watch a video, listen to a podcast or look at a
   product description, how long you spent on this service and the web pages you
   visit etc. This is very helpful to understand the relevance of
   (non-advertising) content that is shown to you.
   
   View Illustrations 
   Object to Legitimate Interests Remove Objection

 * UNDERSTAND AUDIENCES THROUGH STATISTICS OR COMBINATIONS OF DATA FROM
   DIFFERENT SOURCES 37 PARTNERS CAN USE THIS PURPOSE
   
   Switch Label
   
   Reports can be generated based on the combination of data sets (like user
   profiles, statistics, market research, analytics data) regarding your
   interactions and those of other users with advertising or (non-advertising)
   content to identify common characteristics (for instance, to determine which
   target audiences are more receptive to an ad campaign or to certain
   contents).
   
   View Illustrations 
   Object to Legitimate Interests Remove Objection

 * DEVELOP AND IMPROVE SERVICES 53 PARTNERS CAN USE THIS PURPOSE
   
   Switch Label
   
   Information about your activity on this service, such as your interaction
   with ads or content, can be very helpful to improve products and services and
   to build new products and services based on user interactions, the type of
   audience, etc. This specific purpose does not include the development or
   improvement of user profiles and identifiers.
   
   View Illustrations 
   Object to Legitimate Interests Remove Objection

 * USE LIMITED DATA TO SELECT CONTENT 10 PARTNERS CAN USE THIS PURPOSE
   
   Switch Label
   
   Content presented to you on this service can be based on limited data, such
   as the website or app you are using, your non-precise location, your device
   type, or which content you are (or have been) interacting with (for example,
   to limit the number of times a video or an article is presented to you).
   
   View Illustrations 
   Object to Legitimate Interests Remove Objection

List of IAB Vendors‎

USE PRECISE GEOLOCATION DATA 18 PARTNERS CAN USE THIS SPECIAL FEATURE

Use precise geolocation data

With your acceptance, your precise location (within a radius of less than 500
metres) may be used in support of the purposes explained in this notice.

List of IAB Vendors‎

ACTIVELY SCAN DEVICE CHARACTERISTICS FOR IDENTIFICATION 3 PARTNERS CAN USE THIS
SPECIAL FEATURE

Actively scan device characteristics for identification

With your acceptance, certain characteristics specific to your device might be
requested and used to distinguish it from other devices (such as the installed
fonts or plugins, the resolution of your screen) in support of the purposes
explained in this notice.

List of IAB Vendors‎

ENSURE SECURITY, PREVENT AND DETECT FRAUD, AND FIX ERRORS 50 PARTNERS CAN USE
THIS SPECIAL PURPOSE

Always Active

Your data can be used to monitor for and prevent unusual and possibly fraudulent
activity (for example, regarding advertising, ad clicks by bots), and ensure
systems and processes work properly and securely. It can also be used to correct
any problems you, the publisher or the advertiser may encounter in the delivery
of content and ads and in your interaction with them.

List of IAB Vendors‎ | View Illustrations 

DELIVER AND PRESENT ADVERTISING AND CONTENT 44 PARTNERS CAN USE THIS SPECIAL
PURPOSE

Always Active

Certain information (like an IP address or device capabilities) is used to
ensure the technical compatibility of the content or advertising, and to
facilitate the transmission of the content or ad to your device.

List of IAB Vendors‎ | View Illustrations 

MATCH AND COMBINE DATA FROM OTHER DATA SOURCES 41 PARTNERS CAN USE THIS FEATURE

Always Active

Information about your activity on this service may be matched and combined with
other information relating to you and originating from various sources (for
instance your activity on a separate online service, your use of a loyalty card
in-store, or your answers to a survey), in support of the purposes explained in
this notice.

List of IAB Vendors‎

LINK DIFFERENT DEVICES 35 PARTNERS CAN USE THIS FEATURE

Always Active

In support of the purposes explained in this notice, your device might be
considered as likely linked to other devices that belong to you or your
household (for instance because you are logged in to the same service on both
your phone and your computer, or because you may use the same Internet
connection on both devices).

List of IAB Vendors‎

IDENTIFY DEVICES BASED ON INFORMATION TRANSMITTED AUTOMATICALLY 40 PARTNERS CAN
USE THIS FEATURE

Always Active

Your device might be distinguished from other devices based on information it
automatically sends when accessing the Internet (for instance, the IP address of
your Internet connection or the type of browser you are using) in support of the
purposes exposed in this notice.

List of IAB Vendors‎
Back Button


COOKIE LIST



Search Icon
Filter Icon

Clear
checkbox label label
Apply Cancel
Consent Leg.Interest
checkbox label label
checkbox label label
checkbox label label

Confirm My Choices